Description:
INVERTED CHROMOSOME
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Chromosome Abnormalities Pharmacogenetics |
Alternate IDs |
GM17152 [INVERTED CHROMOSOME] |
Cell Type
|
Fibroblast
|
Tissue Type
|
Skin
|
Transformant
|
Untransformed
|
Race
|
Black/African American
|
Country of Origin
|
USA
|
Family Member
|
4
|
Relation to Proband
|
maternal half-brother
|
Confirmation
|
Karyotypic analysis after cell line submission to CCR
|
ISCN
|
46,XY,inv(9)(pter>p11::q1?>p11::q1?> qter)mat
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
Passage Frozen |
2 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Chromosome Analysis |
|
Gene |
CYP2D6 |
Chromosomal Location |
22q13.1 |
Allelic Variant 1 |
R296C; S486T; DEBRISOQUINE, ULTRARAPID METABOLISM OF |
Identified Mutation |
ARG296CYS AND SER486THR |
|
Gene |
CYP2D6 |
Chromosomal Location |
22q13.1 |
Allelic Variant 2 |
124030.0002; DEBRISOQUINE, POOR METABOLISM OF |
Identified Mutation |
DEL; This allelic variant is also known as CYP2D6*5 and CYP2D6(D). In 1 of 42 poor metabolizer individuals (608902), Gough et al. (Nature 347:773-776, 1990) found homozygous deletion of the CYP2D locus. In a poor metabolizer, Gaedigk et al. (Am J Hum Genet 48:943-950, 1991) identified a homozygous 11.5-kb deletion associated with deletion of the entire CYP2D6 gene and total absence of P4502D6 protein in the liver. |
Cytogenetics |
Chromosome 9: INVERSION Breakpoint 9p11 inv(9)9p11 |
|
Chromosome 9: INVERSION Breakpoint 9q10 inv(9)9q10 |
Remarks |
Clinically normal; mother is GM01252; maternal half-brother is GM01253 |
Pope IS, Thuline HC, Aronson MM, Bozarth B, Greene AE, Coriell LL, Duplication of a segment of chromosome 3 in a subject with multiple congenital anomalies and a 47,XYY father, inversion of chromosomes 3 and 9 in the mother, and inversion of chromosome 9 in a brother. Repository identification Nos. GM-1253, GM-1252, and GM-1251. Cytogenet Cell Genet24:127-8 1979 |
PubMed ID: 477407 |
Passage Frozen |
2 |
Split Ratio |
1:3 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Substrate |
None specified |
Subcultivation Method |
trypsin-EDTA |
Supplement |
- |
|
|